Roche secures EU approval for wider use of lung cancer drug

04/29/2010 | Reuters

Roche Holding said European regulators approved Tarceva as a maintenance treatment for advanced nonsmall-cell lung cancer. The drug received FDA approval earlier this month for this indication. Roche also said its Type 2 diabetes treatment taspoglutide yielded positive results in a late-stage trial.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA